Specifically, the kits provide prior authorization information for PCSK9 inhibitors to treat lipid disorders, direct oral anticoagulants for stroke prevention and angiotensin receptor-neprilysin inhibitors for heart failure treatment. Those three categories of drugs were commonly pinpointed as being “always” or “often” denied by insurance companies in surveys of providers.

A technologist at Mississippi Baptist Medical Center in Jackson, Mississippi, has been fired for using a racial slur Aug. 11 at a local donut shop.

On Aug. 9, the FDA expanded its list of valsartan products currently under recall to include other items that contain the active ingredient, which may be tainted with a carcinogenic impurity, manufactured by Hetero Labs Limited in India.

CMS proposed on Aug. 9 an overhaul to accountable care organizations (ACOs), which would require ACOs to more quickly assume financial risk. But critics predict the changes will cause a mass exodus from the Medicare Shared Savings Program.

DiA Imaging Analysis, a Be'er Sheva, Israel-based startup focused on artificial intelligence (AI) and medical imaging, announced this week that it has closed a $5 million round of funding.

Incidental pulmonary nodules detected on chest CT cost a downstream average of $393, researchers reported in a new Academic Radiology study. Collaboration may be the key to reducing that number.

The former business manager of a breast cancer center has been sentenced to 33 months in prison for wire fraud and tax fraud, according to an announcement by U.S. Attorney David C. Joseph.

Some scientists are showing concern after an experiment used a gene-editing tool to fix a potentially fatal heart condition in a human embryo, according to a report by The Wall Street Journal.